{
    "clinical_study": {
        "@rank": "97327", 
        "arm_group": [
            {
                "arm_group_label": "Low-fluence", 
                "arm_group_type": "Experimental", 
                "description": "Low-fluence pan-retinal photocoagulation in a single session for proliferative diabetic retinopathy"
            }, 
            {
                "arm_group_label": "Full-fluence", 
                "arm_group_type": "Active Comparator", 
                "description": "Full-fluence pan-retinal photocoagulation for proliferative diabetic retinopathy"
            }
        ], 
        "brief_summary": {
            "textblock": "To determine the safety and efficacy of a single session of low-fluence panretinal\n      photocoagulation when compared to full-fluence PRP. Hypothesis: a single-session of\n      low-fluence PRP will be safe regarding the progression of macular edema and the presence of\n      adverse events, and will efficiently induce regression of neovascularization."
        }, 
        "brief_title": "Safety and Efficacy of Low-Fluence PRP for PDR", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Proliferative Diabetic Retinopathy", 
        "condition_browse": {
            "mesh_term": [
                "Diabetic Retinopathy", 
                "Retinal Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Type 1 or type 2 diabetics\n\n          -  Proliferative diabetic retinopathy\n\n        Exclusion Criteria:\n\n          -  Previous treatment with PRP\n\n          -  Media opacities\n\n          -  Previous treatment for macular edema (LASER or intravitreal injections)\n\n          -  Recent (less than 6 months) ophthalmic surgery\n\n          -  Only eyes\n\n          -  Intra-retinal or sub-retinal fluid with foveal involvement\n\n          -  Chronic renal failure\n\n          -  History of liver or pancreatic transplant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01737957", 
            "org_study_id": "APEC-LFPRP"
        }, 
        "intervention": [
            {
                "arm_group_label": "Low-fluence", 
                "description": "To administer low-fluence PRP in a single session for PDR", 
                "intervention_name": "Low-fluence PRP with 532nm green LASER", 
                "intervention_type": "Device", 
                "other_name": "PURE-POINT LASER"
            }, 
            {
                "arm_group_label": "Full-fluence", 
                "description": "To administer full-fluence PRP in two sessions for PDR", 
                "intervention_name": "Full-Fluence PRP with 532nm LASER", 
                "intervention_type": "Device", 
                "other_name": "PURE-POINT LASER"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Proliferative Diabetic retinopathy", 
            "Pan-retinal photocoagulation"
        ], 
        "lastchanged_date": "November 28, 2012", 
        "location": {
            "contact": {
                "email": "yokoburgoa@yahoo.com", 
                "last_name": "Yoko Burgoa", 
                "phone": "(52) 55 10841400", 
                "phone_ext": "1172"
            }, 
            "facility": {
                "address": {
                    "city": "Mexico City", 
                    "country": "Mexico", 
                    "state": "DF", 
                    "zip": "04030"
                }, 
                "name": "Asociaci\u00f3n Para Evitar la Ceguera en M\u00e9xico"
            }, 
            "investigator": {
                "last_name": "Guillermo Salcedo-Villanueva, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "2", 
        "official_title": "Safety and Efficacy of Single-session, Low-fluence Panretinal Photocoagulation (PRP) for Proliferative Diabetic Retinopathy (PDR)", 
        "other_outcome": {
            "description": "Regression of neovessels observed by fluorescein angiography", 
            "measure": "Regression of neovessels, change over time", 
            "safety_issue": "No", 
            "time_frame": "Base-line, 1 week, 6 weeks, 12 weeks, 16 weeks"
        }, 
        "overall_official": {
            "affiliation": "APEC", 
            "last_name": "Guillermo Salcedo-Villanueva, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Mexico: Secretaria de Salud", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurement of macular thickness changes by spectral domain optical coherence tomography (OCT)", 
            "measure": "Macular thickness change", 
            "safety_issue": "Yes", 
            "time_frame": "Base-line, 1 week, 6 weeks, 12 weeks, 16 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01737957"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asociaci\u00f3n para Evitar la Ceguera en M\u00e9xico", 
            "investigator_full_name": "Guillermo Salcedo-Villanueva", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Presence or absence of adverse events", 
            "measure": "Adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "16 weeks"
        }, 
        "source": "Asociaci\u00f3n para Evitar la Ceguera en M\u00e9xico", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Asociaci\u00f3n para Evitar la Ceguera en M\u00e9xico", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}